Cumberland Seeks To Block Perrigo's Generic Acetadote

Law360, New York (August 10, 2012, 3:10 PM EDT) -- Cumberland Pharmaceuticals Inc. on Thursday continued its campaign to protect its acetaminophen-overdose treatment Acetadote from challengers, accusing generics maker Perrigo Co. of patent infringement in Illinois federal court.

Cumberland alleges that Perrigo is seeking to undermine Cumberland's business by looking for regulatory approval to market an Acetadote copy prior to the expiration of the original drug's underlying patent issued in April of this year, U.S. Patent Number 8,148,356, titled, "Acetylcysteine composition and uses therefore."

"Perrigo has knowledge of the '356 patent, and Perrigo's actions constitute knowing...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.